Cooperative interaction between Bcl-2 and Epstein-Barr virus latent membrane protein 1 in the growth transformation of human epithelial cells

Journal of General Virology

Volumn 78, Issue 11, 1997, Pages 2975-2985

  Lu, John Jenn Yenn ^a,b   Chen, Jen Yang ^a   Hsu, Tsuey Ying ^a   Yu, Winston C Y ^c   Su, Ih Jen ^a   Yang, Czau Siung ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Department of Health   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; DNA FRAGMENT; MEMBRANE PROTEIN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GEL ELECTROPHORESIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; VIRUS CELL TRANSFORMATION;

HUMAN HERPESVIRUS 4;

EID: 0030698035     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-11-2975     Document Type: Article

References (50)

1. Abdallali, F., Harrington, E. A. & Evan, G. I. (1992). Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359, 554-556.
2. Askew, D. S., Ashmun, R. A., Simmons, B. C. & Cleveland, J. L. (1991). Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6, 1915-1922.
3. Baichwal, V. R. & Sugden, B. (1988). Transformation of Balb/3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 2, 461-467.
4. Chen-Levy, Z. & Cleary, M. L. (1990). Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. Journal of Biological Chemistry 25, 4929-4933.
5. Cohen, J. I., Wang, F. & Kieff, E. (1991). Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. Journal of Virology 65, 2545-2554.
6. Dawson, C. W., Rickinson, A. B. & Young, L. S. (1990). Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344, 777-780.
7. Epstein, M. A., Achong, B. C. & Barr, Y. M. (1964). Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet i, 702-703.
8. Evan, G. I. & Littlewood, T. D. (1993). The role of c-myc in cell growth. Current Opinions in Genetic Development 3, 44-49.
9. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z. & Hancock, D. C. (1992). Induction of apoptosis in fibroblasts by c-Myc protein. Cell 69, 119-128.
10. Fahraeus, R., Fu, J. L., Ernberg, I., Finke, I., Rowe, M., Klein, G., Falk, K., Nilsson, E., Yadav, M., Busson, P., Tursz, T. & Kallin, B. (1988). Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. International Journal of Cancer 42, 329-338.
11. Fahraeus, R., Rymo, L., Rhim, J. S. & Klein, G. (1990). Morphological transformation of human keratinocytes expressing the LMP-1 gene of Epstein-Barr virus. Nature 345, 447-449.
12. Field, J. K. & Spandidos, D. A. (1990). The role of ras and myc oncogenes in human solid tumors and their relevance in diagnosis and prognosis. Anticancer Research 10, 1-22.
13. Gregory, C. D., Dive, C., Henderson, S., Smith, C. A., Williams, G. T., Gordon, J. & Rickinson, A. B. (1991). Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349, 612-614.
14. Henderson, S., Rowe, M., Gregory, C. P., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E. & Rickinson, A. B. (1991). Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65, 1107-1115.
15. Henle, W., Henle, G., Burtin, P., Cachin, Y., Clifford, P., de Schryver, A., de The, G., Diehl, V., Ho, H. C. & Klein, G. (1970). Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasmas and control group. Journal of the National Cancer Institute 44, 225-231.
16. Hockenberry, D., Nunez, G., Milliman, C., Schreiber, R. D. & Korsmeyer, S. J. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336.
17. Hunter, T. (1991). Cooperation between oncogenes. Cell 64, 249-270.
18. Kaye, K. M., Izumi, K. M. & Kieff, E. (1993). Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proceedings of the National Academy of Sciences, USA 90, 9150-9154.
19. Kieff, E. (1996). Epstein-Barr virus and its replication. In Fields Virology, 3rd edn, pp. 2343-2396. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott-Raven.
20. Liebowitz, D., Wang, D. & Kieff, E. (1986). Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. Journal of Virology 58, 233-237.
21. Liebowitz, D., Kopan, R., Fuchs, E., Sample, J. & Kieff, E. (1987). An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Molecular and Cellular Biology 7, 2299-2308.
22. Lu, Q. L., Elia, G., Lucas, S. & Alero Thomas, J. (1993 a). bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. International Journal of Cancer 53, 29-35.
23. Lu, Q. L., Poulson, R., Wong, L. & Hanby, A. M. (1993 b). Bcl-2 expression in adult and embryonic non-haematopoietic tissues. Journal of Pathology 169, 431-437.
24. Lu, P. J., Lu, Q. L., Rughetti, A. & Taylor-Papadimitriou, J. (1995). bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. Journal of Cell Biology 129, 1363-1378.
25. Lu, J. J. Y., Chen, J. Y., Hsu, T. Y., Yu, W. C. Y., Su, I. J. & Yang, C. S. (1996). Induction of apoptosis in epithelial cells by Epstein-Barr virus latent membrane protein 1. Journal of General Virology 77, 1883-1892.
26. Luscher, B. & Eisenman, R. N. (1990). New light on Myc and Myb. Part I. Myc. Genes & Development 4, 2025-2035.
27. McDonnell, T. J. & Korsmeyer, S. J. (1991). Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for t(14;18). Nature 349, 254-256.
28. McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P. & Korsmeyer, S. J. (1989). bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57, 79-88.
29. Mann, K. P., Staunton, D. & Thorley-Lawson, D. A. (1985). Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. Journal of Virology 55, 710-720.
30. Mann, G. J., Dyne, M. & Musgrave, E. A. (1987). Immunofluorescence quantification of ribonucleotide reductase M1 subunit and correlation with DNA content by flow cytometry. Cytometry 8, 509-517.
31. Martin, J. M., Veis, D., Korsmeyer, S. J. & Sugden, B. (1993). Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. Journal of Virology 67, 5269-5278.
32. Nataraj, A., Pathak, S. & Hopwood, V. (1994). bcl-2 oncogene blocks differentiation and extends viability but does not immortalize normal human keratinocytes. International Journal of Oncology 4, 1211-1218.
33. Nunez, G., Seto, M., Seremetis, S., Ferrero, D., Grignani, F., Korsmeyer, S. J. & Dalla-Favera, R. (1989). Growth- and tumor-promoting effects of deregulated Bcl-2 in human B-lymphoblastoid cells. Proceedings of the National Academy of Sciences, USA 86, 4589-4593.
34. Old, L. J., Boyse, W. A., Oettgen, H. F., Deharven, E., Geering, G., Williamson, B. & Clifford, P. (1966). Precipitating antibodies in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proceedings of the National Academy of Sciences, USA 56, 1699-1704.
35. Reed, J. C., Tsujimoto, Y., Alpers, J. D., Croce, C. M. & Nowell, P. C. (1987). Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 236, 1295-1299.
36. Reed, J. C., Cuddy, M., Halder, S., Croce, C., Nowell, P., Makover, D. & Bradley, K. (1990 a). Bcl-2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with c-myc and inhibition by bcl-2 antisense. Proceedings of the National Academy of Sciences, USA 87, 3660-3664.
37. Reed, J. C., Halder, S., Croce, C. M. & Cuddy, M. P. (1990 b). Complementation by bcl-2 and C-HA-ras oncogenes in malignant transformation of rat embryo fibroblasts. Molecular and Cellular Biology 10, 4370-4374.
38. Reed, J. C., Taiwar, S. H., Cuddy, M., Baffy, G., Williamson, J., Rapp, U. R. & Fisher, G. J. (1991). Mitochondrial protein p26 Bcl-2 reduces growth factor requirements of NIH3T3 fibroblasts. Experimental Cell Research 195, 227-283.
39. Rowe, M., Peng-Pilon, M., Huen, D. S., Hardy, R., Croom-Carter, D., Lundgren, E. & Rickinson, A. B. (1994). Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein 1: a B-cell-specific response that is delayed relative to NF-κB activation and to induction of cell surface markers. Journal of Virology 68, 5602-5612.
40. Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Bissonnette, R. P. & Green, D. R. (1992). Role for c-myc in activation-induced apoptotic cell death in T cell lymphomas. Science 257, 212-214.
41. Spencer, C. A. & Groudine, M. (1991). Control of c-myr regulation in normal and neoplastic cells. Advanced Cancer Research 56, 1-48.
42. Strasser, A., Harris, A. W., Bath, M. L. & Cory, S. (1990). Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348, 331-333.
43. Tomkinson, B., Robertson, E. & Kieff, E. (1993). Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocytes growth transformation. Journal of Virology 67, 2014-2025.
44. Tsujimoto, Y. (1989). Overexpression of the human bcl-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proceedings of the National Academy of Sciences, USA 86, 1958-1962.
45. Vaux, D. L., Cory, S. & Adams, J. M. (1988). bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize preB cells. Nature 335, 440-442.
46. Wang, D., Liebowitz, D. & Kieff, E. (1985). An EBV membrane protein expressed in immortalized lymphocytes transformed established rodent cells. Cell 43, 831-840.
47. Wang, D., Liebowitz, D., Wang, F., Gregory, C., Rickinson, A. B., Larson, R., Springer, T. & Kieff, E. (1988). Epstein-Barr virus latent infection membrane protein alters the human B-lymphocytes phenotype: deletion of the amino terminus abolishes activity. Journal of Virology 63, 4173-4184.
48. Wilson, J. B., Weinberg, W., Johnson, R., Yuspa, S. & Levine, A. J. (1990). Expression of the BNLF-1 oncogens of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61, 1315-1327.
49. Young, L. S., Dawson, C. W., Clark, D., Rupani, H., Busson, P., Tursz, T., Johnson, A. & Rickinson, A. B. (1988). Epstein-Barr virus gene expression in nasopharyngeal carcinoma. Journal of General Virology 69, 1051-1061.
50. Young, L., Alfieri, C., Hennessy, K., Evans, H., O'Hara, C., Anderson, K. C., Ritz, J., Shapiro, R. S., Rickinson, A. B., Kieff, E. & Cohen, J. I. (1989). Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. New England Journal of Medicine 321, 1080-1085.